Biofrontera Inc Warrants (27/10/2026) BFRIW 深 滬
等待開盤 05-20 09:30:00 美东时间
0.0222
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.0222
- 總市值 0
- 52周最高 0.277
- 市盈率 靜 --
- 換手率 NaN.00%
- 52周最低 0.0221
- 委 比 -24.59%
- 總股本 --
- 歷史最高 9.18
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.005
- 每 手 1
- 風險率 0.03%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Benchmark Downgrades Biofrontera to Speculative Buy, Maintains Price Target to $3
Benchmark analyst Bruce D. Jackson downgrades Biofrontera (NASDAQ:BFRI) from Buy to Speculative Buy and maintains the price target from $3 to $3.
05-19 20:41
Biofrontera目标2026年实现现金流盈亏平衡 毛利率剑指80%-85%
一季度业绩：营收增长17% 毛利率显著提升至80% Biofrontera近日公布2026年第一季度财报。数据显示，公司一季度产品营收达1010万美元...
05-15 03:09
Transcript: Biofrontera Q1 2026 Earnings Conference Call
On Thursday, Biofrontera (NASDAQ:BFRI) discussed first-quarter financial result...
05-14 23:39
Biofrontera Q1 EPS $(0.41) Misses $(0.12) Estimate, Sales $10.084M Miss $10.250M Estimate
Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.12) by 272.73 percent. This is a 12.77 percent increase over losses of $(0.47) per share from
05-14 20:08
Biofrontera Q1 revenue rises on higher Ameluz sales
Biofrontera Q1 revenue rises on higher Ameluz sales Overview U.S. biopharmaceutical firm's Q1 revenue rose 17% on higher Ameluz sales and price increases Adjusted EBITDA loss narrowed year over year, reflecting improved gross margins under new earnout structure Outlook Company remains focused on ach
05-14 19:40
Earnings Scheduled For May 14, 2026
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
Biofrontera Inc. will report its Q1 2026 financial results on May 14, 2026, after U.S. markets close. A conference call at 11:00 a.m. ET on the same day will discuss the results, provide a business update, and answer questions. The call can be accessed via 1-877-877-1275 (U.S./Canada) or 1-412-858-5202 (international), with a webcast available at https://event.choruscall.com/mediaframe/webcast.html?webcastid=Re1hZKm0. Biofrontera specializes in p...
05-08 20:00
Biofrontera Earnings Call: Profits Rise, Risks Remain
Biofrontera, Inc. (($BFRI)) has held its Q4 earnings call. Read on for the main...
03-20 08:09
Biofrontera Q4 EPS $0.48 Beats $0.20 Estimate, Sales $17.100M Beat $16.146M Estimate
Biofrontera (NASDAQ:BFRI) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.20 by 146.15 percent. This is a 352.63 percent increase over losses of $(0.19) per share from the
03-20 05:49
Biofrontera reports rise in Q4 revenue, turns profitable
Biofrontera (BFRI) reported record Q4 2025 revenue of $17.1M, up 36% year-over-year. Gross margin surged to 82.4%, driven by improved cost structure after its transaction with Biofrontera AG. The comp...
03-20 03:18
